Logo image of SEQUA.BR

SEQUANA MEDICAL NV (SEQUA.BR) Stock Overview

Europe - EBR:SEQUA - BE0974340722 - Common Stock

0.781 EUR
+0.02 (+2.36%)
Last: 10/20/2025, 4:50:42 PM

SEQUA.BR Key Statistics, Chart & Performance

Key Statistics
Market Cap49.32M
Revenue(TTM)N/A
Net Income(TTM)-51852100
Shares63.15M
Float50.39M
52 Week High4.39
52 Week Low0.65
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-1.24
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPO2019-02-11
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment


SEQUA.BR short term performance overview.The bars show the price performance of SEQUA.BR in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -10 -20 -30

SEQUA.BR long term performance overview.The bars show the price performance of SEQUA.BR in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of SEQUA.BR is 0.781 EUR. In the past month the price decreased by -21.01%. In the past year, price decreased by -21.34%.

SEQUANA MEDICAL NV / SEQUA Daily stock chart

SEQUA.BR Competitors/Peers

The largest stocks on the EU markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABL.DE ABBOTT LABORATORIES 26.01 193.30B
IUI1.DE INTUITIVE SURGICAL INC 54.91 135.63B
1ISRG.MI INTUITIVE SURGICAL INC 54.49 134.59B
BSX.DE BOSTON SCIENTIFIC CORP 35.04 125.65B
1MDT.MI MEDTRONIC PLC 17.54 106.40B
2M6.DE MEDTRONIC PLC 17.26 104.72B
SHL.DE SIEMENS HEALTHINEERS AG 20.34 54.62B
BOX.DE BECTON DICKINSON AND CO 13.12 45.95B
EWL.DE EDWARDS LIFESCIENCES CORP 28.68 37.04B
PHIA.AS KONINKLIJKE PHILIPS NV 17.03 23.61B
PHI1.DE KONINKLIJKE PHILIPS NV 16.78 23.26B
DC4.DE DEXCOM INC 38.72 22.17B

About SEQUA.BR

Company Profile

SEQUA logo image Sequana Medical NV is a commercial stage medical device company, which engages in the design, development, manufacture, and commercialization of medical device. The company is headquartered in Ghent, Oost-Vlaanderen and currently employs 48 full-time employees. The company went IPO on 2019-02-11. The firm focuses mainly on the development of treatment solutions for the management of liver disease, heart failure, malignant ascites and other fluid imbalance disorders. Sequana Medical NV provides alfapump, which is an implantable, programmable, wireless-charged and battery-powered system that is CE-marking for the management of refractory ascites due to liver cirrhosis and malignant ascites. Over 650 alfapump systems have been implanted. Apart from the Alfapump, the Company also aims to develop a direct sodium removal (DSR) therapy, which is a propriety approach to the treatment of volume overload in heart failure.

Company Info

SEQUANA MEDICAL NV

Kortrijksesteenweg 1112, Sint-Denijs-Westrem

Ghent OOST-VLAANDEREN BE

Employees: 48

SEQUA Company Website

SEQUA Investor Relations

Phone: 3292928065.0

SEQUANA MEDICAL NV / SEQUA.BR FAQ

What is the stock price of SEQUANA MEDICAL NV today?

The current stock price of SEQUA.BR is 0.781 EUR. The price increased by 2.36% in the last trading session.


What is the ticker symbol for SEQUANA MEDICAL NV stock?

The exchange symbol of SEQUANA MEDICAL NV is SEQUA and it is listed on the Euronext Brussels exchange.


On which exchange is SEQUA.BR stock listed?

SEQUA.BR stock is listed on the Euronext Brussels exchange.


What is the price forecast or stock price prediction for SEQUANA MEDICAL NV stock?

10 analysts have analysed SEQUA.BR and the average price target is 3.57 EUR. This implies a price increase of 357.11% is expected in the next year compared to the current price of 0.781. Check the SEQUANA MEDICAL NV stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is SEQUANA MEDICAL NV worth?

SEQUANA MEDICAL NV (SEQUA.BR) has a market capitalization of 49.32M EUR. This makes SEQUA.BR a Nano Cap stock.


How many employees does SEQUANA MEDICAL NV have?

SEQUANA MEDICAL NV (SEQUA.BR) currently has 48 employees.


What are the support and resistance levels for SEQUANA MEDICAL NV (SEQUA.BR) stock?

SEQUANA MEDICAL NV (SEQUA.BR) has a resistance level at 0.87. Check the full technical report for a detailed analysis of SEQUA.BR support and resistance levels.


Is SEQUANA MEDICAL NV (SEQUA.BR) expected to grow?

The Revenue of SEQUANA MEDICAL NV (SEQUA.BR) is expected to grow by 684.31% in the next year. Check the estimates tab for more information on the SEQUA.BR EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy SEQUANA MEDICAL NV (SEQUA.BR) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does SEQUANA MEDICAL NV (SEQUA.BR) stock pay dividends?

SEQUA.BR does not pay a dividend.


What is the Price/Earnings (PE) ratio of SEQUANA MEDICAL NV (SEQUA.BR)?

SEQUANA MEDICAL NV (SEQUA.BR) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.24).


SEQUA.BR Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

SEQUA.BR Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to SEQUA.BR. SEQUA.BR may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

SEQUA.BR Financial Highlights

Over the last trailing twelve months SEQUA.BR reported a non-GAAP Earnings per Share(EPS) of -1.24. The EPS decreased by -31.63% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -355.86%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%-12.99%
Sales Q2Q%-100%
EPS 1Y (TTM)-31.63%
Revenue 1Y (TTM)-100%

SEQUA.BR Forecast & Estimates

10 analysts have analysed SEQUA.BR and the average price target is 3.57 EUR. This implies a price increase of 357.11% is expected in the next year compared to the current price of 0.781.

For the next year, analysts expect an EPS growth of 38.1% and a revenue growth 684.31% for SEQUA.BR


Analysts
Analysts84
Price Target3.57 (357.11%)
EPS Next Y38.1%
Revenue Next Year684.31%

SEQUA.BR Ownership

Ownership
Inst Owners35.89%
Ins Owners5.35%
Short Float %N/A
Short RatioN/A